Close Menu

NEW YORK – Meridian Bioscience reported on Thursday that its fiscal fourth quarter revenues decreased 4 percent due to competitive pressures in the diagnostics market and pricing declines in its gastrointestinal products.

For the three months ended Sept. 30, the firm reported revenues of $50.8 million down from $53.1 million a year ago. It still beat the average consensus Wall Street estimate of $50.6 million.

Meridian reported Q4 diagnostics revenues of $33.4 million, down 9 percent year over year from $36.8 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.